Nonviral vectors in the new millennium: Delivery barriers in gene transfer

Human Gene Therapy

Volumn 12, Issue 8, 2001, Pages 861-870

  Nishikawa, M ^a   Huang, L ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATION; DNA; DRUG CARRIER; LIPID; PLASMA PROTEIN; PLASMID DNA; POLYMER; VIRUS VECTOR;

BLOOD CELL; BLOOD VESSEL; CAPILLARY; CELL SPECIFICITY; CELL SURFACE; DEGRADATION; DRUG DELIVERY SYSTEM; ELECTROPORATION; ENDOSOME; GENE; GENE GUN; GENE THERAPY; GENE TRANSFER; GENETIC DISORDER; MONONUCLEAR PHAGOCYTE; PHYSICAL CHEMISTRY; PRODUCTIVITY; REVIEW; SYSTEMIC CIRCULATION; TARGET CELL; TECHNIQUE; TISSUE;

ANIMALS; BIOLISTICS; CATIONS; CELL NUCLEUS; CYTOPLASM; ELECTROPORATION; ENDOSOMES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LIPOSOMES; PHAGOCYTES; PLASMIDS;

EID: 0034913116     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303401750195836     Document Type: Review

References (121)

1. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethyleneimine
2. Enhanced gene transfer with fusogenic liposomes containing vesicular stomatitis virus G glycoprotein
3. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs
4. Gene transfer into muscle by electroporation in vivo
5. Direct gene transfer into donor hearts at the time of harvest
6. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial
7. Morphological classification of vertebrate blood capillaries
8. pH-sensitive cationic polymer gene delivery vehicle: N-Ac-poly(L-histidine)-graft-poly(L-lysine) comb shaped polymer
9. Nonviral gene delivery to the rat kidney with polyethyleneimine
10. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethyleneimine
11. In vivo transfection of murine lungs with a functioning prokaryotic gene using a liposome vehicle
12. Naked DNA delivered intraportally expresses efficiently in hepatocytes
13. The efficient expression of intravenously delivered DNA in rat muscle
14. Hypothesis: Naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process
15. High efficiency transformation by direct microinjection of DNA into cultured mammalian cells
16. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
17. Biodistribution, metabolism, and in vivo gene expression of low molecular weight glycopeptide polyethylene glycol peptide DNA co-condensates
18. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery
19. Pharmacological enhancement of in vivo foreign gene expression in muscle
20. Direct gene transfer into skeletal muscle in vivo: Factors affecting efficiency of transfer and stability of expression
21. Import of plasmid DNA into the nucleus is sequence specific
22. Mannose polyethyleneimine conjugates for targeted DNA delivery into dendritic cells
23. Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption
24. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer
25. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure
26. Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor
27. ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo
28. Protective copolymers for nonviral gene vectors: Synthesis, vector characterization and application in gene delivery
29. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethyleneimine: Effect of molecular weight on transfection efficiency and cytotoxicity
30. Polyethyleneimine-based intravenous delivery of transgenes to mouse lung
31. Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector
32. Development of biomaterials for gene therapy
33. Sodium phosphate enhances plasmid DNA expression in vivo
34. In vivo gene electroinjection and expression in rat liver
35. Gene expression following direct injection of DNA into liver
36. Electroporation therapy of solid tumors
37. Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol) phospholipid conjugates for efficient in vivo gene delivery
38. In vitro and in vivo trans-fection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound
39. A pulsed electric field enhances cutaneous delivery of methylene blue in excised full-thickness porcine skin
40. Introduction and expression of the human insulin gene in adult rat liver
41. Increased expression of DNA cointroduced with nuclear protein in adult rat liver
42. Use of targeted cationic liposomes in enhanced DNA delivery to cancer cells
43. The fate of plasmid DNA after intravenous injection in mice: Involvement of scavenger receptors in its hepatic uptake
44. Polycationbased DNA complexes for tumor-targeted gene delivery in vivo
45. Sterically stabilized anti-HER2 immunoliposomes: Design and targeting to human breast cancer cells in vitro
46. CpG motifs in bacterial DNA trigger direct B-cell activation
47. Metabolic stability of plasmid DNA in the cytosol: A potential barrier to gene transfer
48. Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery
49. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: Implications for intravenous lipofection
50. Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors
51. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody
52. Fate of cationic liposomes and their complex with oligonucleotide in vivo
53. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA
54. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery
55. Tissue distribution and persistence in mice of plasmid DNA encapsulated in a PLGA-based microsphere delivery vehicle
56. In vivo disposition characteristics of plasmid DNA complexed with cationic liposomes
57. Physicochemical and pharmacokinetic characteristcs of plasmid DNA/cationic liposome complexes
58. Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment
59. Gene therapy by intramuscular injection of plasmid DNA: Studies on firefly luciferase gene expression in mice
60. Electropermeabilization of skeletal muscle enhances gene transfer in vivo
61. Inflammatory responses following direct injection of plasmid DNA into skeletal muscle
62. Efficient gene transfer by histidylated polylysine/pDNA complexes
63. Specific gene trans-fer mediated by lactosylated poly-L-lysine into hepatoma cells
64. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: Direct access to the cytosol
65. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy
66. High-efficiency gene transfer into skeletal muscle mediated by electric pulses
67. Stabilized plasmid-lipid particles: Pharmacokinetics and plasmid delivery to distal tumors following intravenous injection
68. Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo
69. Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle
70. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans
71. Gene transfer into mouse lyoma cells by electroporation in high electric field
72. Pharmacokinetic analysis of uptake process of lactosaminated albumin in rat liver constant infusion experiments
73. Pharmacokinetic evaluation of polymeric carriers
74. Targeted delivery of plasmid DNA to hepatocytes in vivo: Optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties
75. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system
76. Gene expression and antitumor effects following direct interferon (IFN)-γ gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice
77. PEGylated DNA/transferrin-PEI complexes: Reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery
78. Plasmid DNAs directly injected into mouse brain with lipofectin can be incorporated and expressed by brain cells
79. T3-dependent physiological regulation of transcription in the Xenopus tadpole brain studied by polyethyleneimine based in vivo gene transfer
80. Gene transfer in vivo: Sustained expression and regulation of genes introduced into the liver by receptor-mediated uptake
81. Activation of the complement system by systemic DNA complexes: A potential barrier for intravenous gene delivery
82. Application of membrane-active peptides for drug and gene delivery across cellular membranes
83. Immunotherapy of malignancy by in vivo gene transfer into tumors
84. Intraarterial delivery of adeno-virus vectors and liposome-DNA complexes to experimental brain neoplasms
85. Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses
86. Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: A stage toward artificial viruses
87. Size selectivity of blood-brain barrier permeability at various times after osmotic opening
88. In vivo electrically mediated protein and gene transfer in murine melanoma
89. Surfactant protein A-polylysine conjugates for delivery of DNA to airway cells in culture
90. Effect of poly(vinylpyrrolidone) on the thermal phase transition of 1,2-dipalmitoyl-1-sn-glycero-3-phosphocholinie bilayer
91. Multicomponent DNA carrier with a vesicular stomatitis virus G-peptide greatly enhances liver-targeted gene expression in mice
92. Gene transfer by naked DNA into adult mouse brain
93. Fate and behavior of liposomes in vivo: A review of controlling factors
94. In vivo gene transfer into rabbit thyroid follicular cells by direct DNA injection
95. Theory and in vivo application of electroporative gene delivery
96. Factors influencing the drug sensitization of human tumor cells for in situ lipofection
97. Macromolecular carrier systems for targeted drug delivery: Pharmacokinetic considerations on biodistribution
98. In vivo electroporation and stable transformation of skin cells of new-born mice by plasmid DNA
99. Immunoliposomes and PEGylated immunoliposomes: Possible use for targeted delivery of imaging agents
100. Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid: Plasmid DNA complexes in mice
101. In vitro and in vivo targeting of gene expression to melanoma cells
102. Transferrin-polycation conjugates as carriers for DNA uptake into cells
103. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: Toward a synthetic virus-like gene-transfer vehicle
104. Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscle
105. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles
106. Direct gene transfer into mouse muscle in vivo
107. Conditions affecting direct gene transfer into rodent muscle in vivo
108. Receptor-mediated gene delivery and expression in vivo
109. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection
110. Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA
111. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment
112. Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid: pDNA complexes
113. Direct in vivo gene transfer to urological organs
114. Cellular and molecular barriers to gene transfer by a cationic lipid
115. Gene delivery: A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus
116. Bacterial β-galactosidase and human dystrophin genes are expressed in mouse skeletal fibers after ballistic transfection
117. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA
118. DNA transfection mediated by cationic liposomes containing lipopolylysine: Characterization and mechanism of action
119. Systemic gene expression after intravenous DNA delivery into adult mice